BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20501482)

  • 1. Impact of reduction in early- and late-systolic functional mitral regurgitation on reverse remodelling after cardiac resynchronization therapy.
    Liang YJ; Zhang Q; Fung JW; Chan JY; Yip GW; Lam YY; Yu CM
    Eur Heart J; 2010 Oct; 31(19):2359-68. PubMed ID: 20501482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and late effects of cardiac resynchronization therapy on exercise-induced mitral regurgitation: relationship with left ventricular dyssynchrony, remodelling and cardiopulmonary performance.
    Madaric J; Vanderheyden M; Van Laethem C; Verhamme K; Feys A; Goethals M; Verstreken S; Geelen P; Penicka M; De Bruyne B; Bartunek J
    Eur Heart J; 2007 Sep; 28(17):2134-41. PubMed ID: 17504802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repercussion of functional mitral regurgitation on reverse remodelling in cardiac resynchronization therapy.
    Cabrera-Bueno F; García-Pinilla JM; Peña-Hernández J; Jiménez-Navarro M; Gómez-Doblas JJ; Barrera-Cordero A; Alzueta-Rodríguez J; de Teresa-Galván E
    Europace; 2007 Sep; 9(9):757-61. PubMed ID: 17573358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential change in left ventricular mass and regional wall thickness after cardiac resynchronization therapy for heart failure.
    Zhang Q; Fung JW; Auricchio A; Chan JY; Kum LC; Wu LW; Yu CM
    Eur Heart J; 2006 Jun; 27(12):1423-30. PubMed ID: 16682380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effect of cardiac resynchronization therapy on functional mitral valve regurgitation.
    Sitges M; Vidal B; Delgado V; Mont L; Garcia-Alvarez A; Tolosana JM; Castel A; Berruezo A; Azqueta M; Pare C; Brugada J
    Am J Cardiol; 2009 Aug; 104(3):383-8. PubMed ID: 19616672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different determinants of improvement of early and late systolic mitral regurgitation contributed after cardiac resynchronization therapy.
    Liang YJ; Zhang Q; Fung JW; Chan JY; Yip GW; Lam YY; Lee AP; Yu CM
    J Am Soc Echocardiogr; 2010 Nov; 23(11):1160-7. PubMed ID: 20800439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure.
    Porciani MC; Macioce R; Demarchi G; Chiostri M; Musilli N; Cappelli F; Lilli A; Ricciardi G; Padeletti L
    Eur J Echocardiogr; 2006 Jan; 7(1):31-9. PubMed ID: 16378918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of improvement in mitral regurgitation after cardiac resynchronization therapy.
    Ypenburg C; Lancellotti P; Tops LF; Boersma E; Bleeker GB; Holman ER; Thomas JD; Schalij MJ; Piérard LA; Bax JJ
    Eur Heart J; 2008 Mar; 29(6):757-65. PubMed ID: 18305084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of mitral regurgitation and myocardial viability on left ventricular reverse remodeling after cardiac resynchronization therapy in patients with ischemic cardiomyopathy.
    Sénéchal M; Lancellotti P; Magne J; Garceau P; Champagne J; Philippon F; O'Hara G; Moonen M; Dubois M
    Am J Cardiol; 2010 Jul; 106(1):31-7. PubMed ID: 20609643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of cardiac resynchronization therapy on the severity of mitral regurgitation.
    Di Biase L; Auricchio A; Mohanty P; Bai R; Kautzner J; Pieragnoli P; Regoli F; Sorgente A; Spinucci G; Ricciardi G; Michelucci A; Perrotta L; Faletra F; Mlcochová H; Sedlacek K; Canby R; Sanchez JE; Horton R; Burkhardt JD; Moccetti T; Padeletti L; Natale A
    Europace; 2011 Jun; 13(6):829-38. PubMed ID: 21486916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of a new left ventricular asynchrony index as a predictor of reverse remodelling after cardiac resynchronization therapy.
    Porciani MC; Lilli A; Macioce R; Cappelli F; Demarchi G; Pappone A; Ricciardi G; Padeletti L
    Eur Heart J; 2006 Aug; 27(15):1818-23. PubMed ID: 16818457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy.
    Bax JJ; Bleeker GB; Marwick TH; Molhoek SG; Boersma E; Steendijk P; van der Wall EE; Schalij MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1834-40. PubMed ID: 15519016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up.
    Ypenburg C; van Bommel RJ; Borleffs CJ; Bleeker GB; Boersma E; Schalij MJ; Bax JJ
    J Am Coll Cardiol; 2009 Feb; 53(6):483-90. PubMed ID: 19195605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging.
    Yu CM; Zhang Q; Fung JW; Chan HC; Chan YS; Yip GW; Kong SL; Lin H; Zhang Y; Sanderson JE
    J Am Coll Cardiol; 2005 Mar; 45(5):677-84. PubMed ID: 15734610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incremental value of global systolic dyssynchrony in determining the occurrence of functional mitral regurgitation in patients with left ventricular systolic dysfunction.
    Liang YJ; Zhang Q; Fang F; Lee AP; Liu M; Yan BP; Lam YY; Chan GC; Yu CM
    Eur Heart J; 2013 Mar; 34(10):767-74. PubMed ID: 22613344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in mitral regurgitation in patients undergoing cardiac resynchronization treatment: assessment of predictors by two-dimensional radial strain echocardiography.
    Goland S; Rafique AM; Mirocha J; Siegel RJ; Naqvi TZ
    Echocardiography; 2009 Apr; 26(4):420-30. PubMed ID: 19382944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrical conduction disturbance effects on dynamic changes of functional mitral regurgitation.
    Fukuda S; Grimm R; Song JM; Kihara T; Daimon M; Agler DA; Wilkoff BL; Natale A; Thomas JD; Shiota T
    J Am Coll Cardiol; 2005 Dec; 46(12):2270-6. PubMed ID: 16360057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE).
    Sutton MG; Plappert T; Hilpisch KE; Abraham WT; Hayes DL; Chinchoy E
    Circulation; 2006 Jan; 113(2):266-72. PubMed ID: 16401777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between acute improvement in left ventricular function to 6-month outcomes after cardiac resynchronization therapy in patients with chronic heart failure.
    Pires LA; Ghio S; Chung ES; Tavazzi L; Abraham WT; Gerritse B
    Congest Heart Fail; 2011; 17(2):65-70. PubMed ID: 21449994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of right ventricular lead location on response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Haghjoo M; Bonakdar HR; Jorat MV; Fazelifar AF; Alizadeh A; Ojaghi-Haghjghi Z; Esmaielzadeh M; Sadr-Ameli MA
    Europace; 2009 Mar; 11(3):356-63. PubMed ID: 19136489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.